Vertex (VRTX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Vertex(VRTX) Zacks Investment Research·2024-05-08 22:36
For the quarter ended March 2024, Vertex Pharmaceuticals (VRTX) reported revenue of 4.76, compared to 2.56 billion, representing a surprise of +5.15%. The company delivered an EPS surprise of +16.10%, with the consensus EPS estimate being $4.10. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings ...